Immunoglobulin G3 and immunoglobulin M isotype plasma levels are influenced by interleukin-1α genotype

Scandinavian Journal of Immunology

Volumn 57, Issue 3, 2003, Pages 296-302

  Kilpinen, S ^a   Laine, S ^a   Hulkkonen, J ^a   Hurme, M ^a  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS; INTERLEUKIN 1ALPHA;

ADULT; ANTIBODY RESPONSE; ARTICLE; COMPLEMENT ACTIVATION; FEMALE; GENE CONTROL; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; INTERLEUKIN-1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0037343464     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01231.x     Document Type: Article

References (40)

1. Allansmith M, McClellan BH, Butterworth M, Maloney JR. The development of immunoglobulin levels in man. J Pediatr 1968;72:276-90.
2. Allansmith M, McClellan B, Butterworth M. The influence of heredity and environment on human immunoglobulin levels. J Immunol 1969;102:1504-10.
3. Allansmith M, McClellan B, Butterworth M. Stability of human immunoglobulin levels. Exp Biol Med 1967;125:404-7.
4. Lee SK, Metrakos JD, Tanaka KR, Heiner DC. Genetic influence on serum IgD levels. Pediatr Res 1980;14:60-3.
5. Kohler PF, Rivera VJ, Eckert ED, Bouchard Jr TJ, Heston LL. Genetic regulation of immunoglobulin and specific antibody levels in twins reared apart. J Clin Invest 1985;75:883-8.
6. Judson IR, Wiltshaw E, Newland AC. Multiple myeloma in a pair of monozygotic twins: the first reported case. Br J Haematol 1985;60:551-4.
7. Grundbacher FJ. Heritability estimates and genetic and environmental correlations for the human immunoglobulins G, M, and A. Am J Hum Genet 1974;26:1-12.
8. Staruch MJ, Wood DD. The adjuvanticity of interleukin 1 in vivo. J Immunol 1983;130:2191-4.
9. Nencioni L, Villa L, Tagliabue A et al. In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta. J Immunol 1987;139:800-4.
10. Boraschi D, Nencioni L, Villa L et al. In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta. J Exp Med 1988;168:675-86.
11. Tagliabue A, Boraschi D. Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171. Vaccine 1993;11:594-5.
12. Lofthouse SA, Andrews AE, Barcham GJ, Nash AD. Parameters related to the application of recombinant ovine interleukin-1 beta as an adjuvant. Vaccine 1995;13:1277-87.
13. Hakim I, Levy S, Levy R. A nine-amino acid peptide from IL-1 beta augments antitumor immune responses induced by protein and DNA vaccines. J Immunol 1996;157:5503-11.
14. Staats HF, Ennis Jr FA. IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. J Immunol 1999;162:6141-7.
15. Boraschi D, Tagliabue A. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants. Methods 1999;19:108-13.
16. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
17. Bromander A, Holmgren J, Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol 1991;146:2908-14.
18. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993;54:229-70.
19. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994;19:382-4.
20. Haugen A, Mann D, Murray C, Weston A, Willey JC. Interleukin-1 alpha gene intron containing variable repeat region coding for the SP1 transcription factor recognition sequence is polymorphic. Mol Carcinog 1989;2:68-71.
21. Todd S, Naylor SL. Dinucleotide repeat polymorphism in the human interleukin 1, alpha gene (IL1A). Nucleic Acids Res 1991;19:3756.
22. Bailly S, di Giovine FS, Blakemore AI, Duff GW. Genetic polymorphism of human interleukin-1 alpha. Eur J Immunol 1993;23:1240-5.
23. McDowell TL, Symons JA, Ploski R, Forte O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995;38:221-8.
24. Cox A, Camp NJ, Cannings C et al. Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet 1999;8:1707-13.
25. Kornman KS, Crane A, Wang HY et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-7.
26. Diehl SR, Wang Y, Brooks CN et al. Linkage disequilibrium of interleukin-1 genetic polymorphisms with early-onset periodontitis. J Periodontol 1999;70:418-30.
27. Nicoll JA, Mrak RE, Graham DI et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 2000;47:365-8.
28. Murphy Jr GM, Claassen JD, DeVoss JJ et al. Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889*1 allele. Neurology 2001;56:1595-7.
29. Hulkkonen J, Laippala P, Hurme M. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw 2000;11:251-5.
30. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991;110:559-65.
31. Matsuda M, Sakamoto N, Fukumaki Y. Delta-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the delta-globin gene promoter. Blood 1992;80:1347-51.
32. Smith JD, Brinton EA, Breslow JL. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest 1992;89:1796-800.
33. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
34. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275:18138-44.
35. Muraguchi A, Hirano T, Tang B et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988;167:332-44.
36. Kawano Y, Noma T, Yata J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 1994;153:4948-58.
37. Dougherty GJ, Selvendran Y, Murdoch S, Palmer DG, Hogg N. The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur J Immunol 1987;17:1453-9.
38. Fanger NA, Voigtlaender D, Liu C et al. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells. J Immunol 1997;158:3090-8.
39. Read RC, Camp NJ, di Giovine FS et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 2000;182:1557-60.
40. Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998;62:1180-8.